HAEMONETICS CORP (HAE) — key financial figures for fiscal year 2026 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2026)

$1.3B

Net Income/Loss (FY2026)

$97.3M

Total Assets (FY2026)

$2.4B

Total Equity (FY2026)

$796.3M

Cash Flows from Operating Activities (FY2026)

$293.2M

Source: HAEMONETICS CORP 10-K filing (FY2026). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.